Indications and contraindications to lung transplant: Patient selection;Indications et contre-indications à la greffe pulmonaire sélection du receveur

Revue de Pneumologie Clinique

Volumn 67, Issue 1, 2010, Pages 5-14

  Kanaan, R ^a  

^a Hôpital Cochin AP HP ^*  (France)

Author keywords

Contraindication; Death risk before lung transplant; Indication; Lung transplant; Lung transplant preparation; Receiver selection

Indexed keywords

AGE; ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; CYSTIC FIBROSIS; DIABETES MELLITUS; DISEASE SEVERITY; EXERCISE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HUMAN; HYPERTENSION; LUNG EMPHYSEMA; LUNG FIBROSIS; LUNG TRANSPLANTATION; MEDICAL ASSESSMENT; MENTAL DISEASE; MORBIDITY; MORTALITY; NEOPLASM; NUTRITIONAL SUPPORT; PATIENT MONITORING; PATIENT REFERRAL; PATIENT SELECTION; PROGNOSIS; PULMONARY HYPERTENSION; QUALITY OF LIFE; RECIPIENT; REHABILITATION CARE; RISK ASSESSMENT; SURVIVAL; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VIRUS INFECTION;

HUMANS; LUNG TRANSPLANTATION; PATIENT SELECTION;

EID: 79951947691     PISSN: 07618417     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneumo.2010.12.003     Document Type: Article

References (41)

1. Glanville A.R., Estenne M. Indications, patient selection and timing of referral for lung transplantation. Eur Respir J 2003, 845-852.
2. Orens J.B., Estenne M., Arcasoy S., Conte J.V., Corris P., Egan J.J., et al. International guidelines for the selection of lung transplant candidates: 2006 update - a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2006, 25:745-755.
3. Trulock E.P., Christie J.D., Edwards L.B., Boucek M.M., Aurora P., Taylor D.O., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report - 2007. J Heart Lung Transplant. 2007, 26:782-795.
4. Weiss E.S., Merlo C.A., Shah A.S. Impact of advanced age in lung transplantation: an analysis of United Network for Organ Sharing data. J Am Coll Surg. 2009, 208:400-409.
5. Izbicki G., Ben-Dor I., Shitrit D., Bendayan D., Aldrich T.K., Kornowski R., et al. The prevalence of coronary artery disease in end-stage pulmonary disease: is pulmonary fibrosis a risk factor?. Respir Med. 2009, 103:1346-1349.
6. Harringer W., Haverich A. Heart and heart-lung transplantation: standards and improvements. World J Surg. 2002, 26:218-225.
7. Hadjiliadis D., Chaparro C., Reinsmoen N.L., Gutierrez C., Singer L.G., Steele M.P., et al. Pre-transplant panel reactive antibody in lung transplant recipients is associated with significantly worse post-transplant survival in a multicenter study. J Heart Lung Transplant. 2005, 24:S249-S254.
8. Kellerman L., Neugut A., Burke B., Mancini D. Comparison of the incidence of de novo solid malignancies after heart transplantation to that in the general population. Am J Cardiol. 2009, 103:562-566.
9. Boussaud V., Guillemain R., Grenet D., Coley N., Souilamas R., Bonnette P., et al. Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres. Thorax. 2008, 63:732-737.
10. Symoens F., Knoop C., Schrooyen M., Denis O., Estenne M., Nolard N., et al. Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation. J Heart Lung Transplant. 2006, 25:603-607.
11. Couetil J.P., Houssin D.P., Soubrane O., Chevalier P.G., Dousset B.E., Loulmet D., et al. Combined lung and liver transplantation in patients with cystic fibrosis. A 4 1/2-year experience. J Thorac Cardiovasc Surg. 1995, 110:1415-1422. [discussion 22-3].
12. Milkiewicz P., Skiba G., Kelly D., Weller P., Bonser R., Gur U., et al. Transplantation for cystic fibrosis: outcome following early liver transplantation. J Gastroenterol Hepatol. 2002, 17:208-213.
13. Fischer S., Bennett L.E.M., Strueber M., Waddell T.K., Niedermeier J., Keshavjee S., et al. Outcome following simultaneous and sequential lung-liver transplantation: analysis of the ISHLT/UNOS joint thoracic registry. J Heart Lung Transplant. 2002, 21:108-109.
14. Hadjiliadis D., Madill J., Chaparro C., Tsang A., Waddell T.K., Singer L.G., et al. Incidence and prevalence of diabetes mellitus in patients with cystic fibrosis undergoing lung transplantation before and after lung transplantation. Clin Transplant. 2005, 19:773-778.
15. Brennan A.L., Geddes D.M., Gyi K.M., Baker E.H. Clinical importance of cystic fibrosis-related diabetes. J Cyst Fibros. 2004, 3:209-222.
16. Snell G.I., Bennetts K., Bartolo J., Levvey B., Griffiths A., Williams T., et al. Body mass index as a predictor of survival in adults with cystic fibrosis referred for lung transplantation. J Heart Lung Transplant. 1998, 17:1097-1103.
17. Haworth C.S., Webb A.K., Egan J.J., Selby P.L., Hasleton P.S., Bishop P.W., et al. Bone histomorphometry in adult patients with cystic fibrosis. Chest. 2000, 118:434-439.
18. Dobbels F., Vanhaecke J., Dupont L., Nevens F., Verleden G., Pirenne J., et al. Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation. 2009, 87:1497-1504.
19. Bertani A., Grossi P., Vitulo P., D'Ancona G., Arcadipane A., Nanni Costa A., et al. Successful lung transplantation in an HIV- and HBV-positive patient with cystic fibrosis. Am J Transplant. 2009, 9:2190-2196.
20. De Soyza A., Archer L., Wardle J., Parry G., Dark J.H., Gould K., et al. Pulmonary transplantation for cystic fibrosis: pre-transplant recipient characteristics in patients dying of peri-operative sepsis. J Heart Lung Transplant. 2003, 22:764-769.
21. Meyers B.F., Lynch J.P., Battafarano R.J., Guthrie T.J., Trulock E.P., Cooper J.D., et al. Lung transplantation is warranted for stable, ventilator-dependent recipients. Ann Thorac Surg. 2000, 70:1675-1678.
22. Kerem E., Reisman J., Corey M., Canny G.J., Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med. 1992, 326:1187-1191.
23. Hosenpud J.D., Bennett L.E., Keck B.M., Edwards E.B., Novick R.J. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet. 1998, 351:24-27.
24. Studer S.M., Krishnan J.A., Orens J.B. Indications for lung transplant referral: physician attitudes. J Heart Lung Transplant. 2002, 21:716-717.
25. Rosenbluth D.B., Wilson K., Ferkol T., Schuster D.P. Lung function decline in cystic fibrosis patients and timing for lung transplantation referral. Chest. 2004, 126:412-419.
26. Ellaffi M., Vinsonneau C., Coste J., Hubert D., Burgel P.R., Dhainaut J.F., et al. One-year outcome after severe pulmonary exacerbation in adults with cystic fibrosis. Am J Respir Crit Care Med. 2005, 171:158-164.
27. Egan T.M., Murray S., Bustami R.T., Shearon T.H., McCullough K.P., Edwards L.B., et al. Development of the new lung allocation system in the United States. Am J Transplant. 2006, 6:1212-1227.
28. Russo M.J., Davies R.R., Hong K.N., Iribarne A., Kawut S., Bacchetta M., et al. Who is the high-risk recipient? Predicting mortality after lung transplantation using pretransplant risk factors. J Thorac Cardiovasc Surg. 2009, 138:1234-1238 e1.
29. Maurer J.R., Frost A.E., Estenne M., Higenbottam T., Glanville A.R. International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. Transplantation. 1998, 66:951-956.
30. Celli B.R., Cote C.G., Marin J.M., Casanova C., Montes de Oca M., Mendez R.A., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004, 350:1005-1012.
31. Thabut G., Mal H., Castier Y., Groussard O., Brugiere O., Marrash-Chahla R., et al. Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis. J Thorac Cardiovasc Surg. 2003, 126:469-475.
32. ATS/ERS. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002;165:277-304.
33. Takaoka S.T., Weinacker A.B. The value of preoperative pulmonary rehabilitation. Thorac Surg Clin. 2005, 15:203-211.
34. Berry M.J., Rejeski W.J., Adair N.E., Zaccaro D. Exercise rehabilitation and chronic obstructive pulmonary disease stage. Am J Respir Crit Care Med. 1999, 160:1248-1253.
35. Kanasky W.F., Anton S.D., Rodrigue J.R., Perri M.G., Szwed T., Baz M.A. Impact of body weight on long-term survival after lung transplantation. Chest. 2002, 121:401-406.
36. Forsythe J., Cooley K., Greaver B. Adaptation of a weight management program for a potential lung transplant candidate. Prog Transplant. 2000, 10:234-238.
37. Mattner F., Fischer S., Weissbrodt H., Chaberny I.F., Sohr D., Gottlieb J., et al. Postoperative nosocomial infections after lung and heart transplantation. J Heart Lung Transplant. 2007, 26:241-249.
38. Olivier K.N., Weber D.J., Wallace R.J., Faiz A.R., Lee J.H., Zhang Y., et al. Nontuberculous mycobacteria I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med. 2003, 167:828-834.
39. Chalermskulrat W., Sood N., Neuringer I.P., Hecker T.M., Chang L., Rivera M.P., et al. Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation. Thorax. 2006, 61:507-513.
40. Balfour I.C., Fiore A., Graff R.J., Knutsen A.P. Use of rituximab to decrease panel-reactive antibodies. J Heart Lung Transplant. 2005, 24:628-630.
41. Ullrich G., Jänsch H., Schmidt S., Strüber M., Niedermeyer J. The experience of the support person involved in a lung transplant programme: results of a pilot study. Eur J Med Res 2004, 9:555-652.